Publication Date
In 2025 | 0 |
Since 2024 | 0 |
Since 2021 (last 5 years) | 0 |
Since 2016 (last 10 years) | 0 |
Since 2006 (last 20 years) | 1 |
Descriptor
Cognitive Ability | 2 |
Control Groups | 2 |
Patients | 2 |
Clinical Diagnosis | 1 |
Dementia | 1 |
Depression (Psychology) | 1 |
Diseases | 1 |
Head Injuries | 1 |
Incidence | 1 |
Intelligence | 1 |
Measures (Individuals) | 1 |
More ▼ |
Source
Assessment | 2 |
Author
Brooks, Brian L. | 1 |
Culbertson, William | 1 |
Duda, John | 1 |
Holdnack, James A. | 1 |
Iverson, Grant L. | 1 |
Moberg, Paul | 1 |
Stern, Matthew | 1 |
Weintraub, Daniel | 1 |
Publication Type
Journal Articles | 2 |
Reports - Research | 2 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
Wechsler Adult Intelligence… | 1 |
What Works Clearinghouse Rating
Brooks, Brian L.; Holdnack, James A.; Iverson, Grant L. – Assessment, 2011
Clinicians can use the base rates of low scores in healthy people to reduce the likelihood of misdiagnosing cognitive impairment. In the present study, base rates were developed for the Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV) and Wechsler Memory Scale-Fourth Edition (WMS-IV) using 900 healthy adults and validated on 28 patients…
Descriptors: Intelligence, Incidence, Head Injuries, Patients
Culbertson, William; Moberg, Paul; Duda, John; Stern, Matthew; Weintraub, Daniel – Assessment, 2004
The aim of the study was to investigate the utility of the Tower of London-Drexel (TOL DX ) in assessing the executive deficits associated with Parkinsons disease (PD). We sought to determine whether the TOL DX would differentiate between (a) patients with PD and healthy control participants (HCP), (b) demented and nondemented patients, and (c)…
Descriptors: Patients, Diseases, Test Validity, Dementia